{"nct_id":"NCT05139017","title":"A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-01-14","start_date_type":"ACTUAL","primary_completion_date":"2027-09-24","primary_completion_date_type":"ESTIMATED","completion_date":"2027-09-24","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["MRK"]}